Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets
NCT05002231
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Adult Subjects
Interventions
DRUG:
Losmapimod 15 mg oral tablet
DRUG:
Losmapimod two 7.5 mg oral tablets
DRUG:
Losmapimod one 15 mg oral tablet
Sponsor
Fulcrum Therapeutics